Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paolo Rainone, Antonella De Palma, Francesco Sudati, Valentina Roffia, Valentina Rigamonti, Lucia Salvioni, Miriam Colombo, Marilena Ripamonti, Antonello Enrico Spinelli, Davide Mazza, Pierluigi Mauri, Rosa Maria Moresco, Davide Prosperi & Sara Belloli. (2021) 99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer. International Journal of Nanomedicine 16, pages 1943-1960.
Read now
Read now
Hanieh Sadeghi, Aryan Kamal, Marzieh Ahmadi, Hadi Najafi, Ali Sharifi Zarchi, Peyman Haddad, Bahareh Shayestehpour, Leila Kamkar, Masoumeh Salamati, Loabat Geranpayeh, Marzieh Lashkari & Mehdi Totonchi. (2021) A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages. RNA Biology 18:sup2, pages 747-756.
Read now
Read now
Menha Swellam, Rasha F. K. Zahran, Hossam Abo El-Sadat Taha, Nashwa El-Khazragy & Camelia Abdel-Malak. (2019) Role of some circulating MiRNAs on breast cancer diagnosis. Archives of Physiology and Biochemistry 125:5, pages 456-464.
Read now
Read now
Paolo Rainone, Benedetta Riva, Sara Belloli, Francesco Sudati, Marilena Ripamonti, Paolo Verderio, Miriam Colombo, Barbara Colzani, Maria Carla Gilardi, Rosa Maria Moresco & Davide Prosperi. (2017) Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer. International Journal of Nanomedicine 12, pages 3447-3461.
Read now
Read now
Articles from other publishers (10)
Alicia M. DeLouize, Geeta Eick, Sana D. Karam & J. Josh Snodgrass. (2021) Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population‐based research. American Journal of Human Biology 34:11.
Crossref
Crossref
Anqi Ge, Lifang Liu, Xian’guang Deng, Jun Luo & Yanghua Xu. (2021) Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics Strategies. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Crossref
Gangga Anuraga, Wei-Jan Wang, Nam Nhut Phan, Nu Thuy An Ton, Hoang Dang Khoa Ta, Fidelia Berenice Prayugo, Do Thi Minh Xuan, Su-Chi Ku, Yung-Fu Wu, Vivin Andriani, Muhammad Athoillah, Kuen-Haur Lee & Chih-Yang Wang. (2021) Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer. Journal of Personalized Medicine 11:11, pages 1089.
Crossref
Crossref
Adriana P. Mamede, Inês P. Santos, Ana L. M. Batista de Carvalho, Paulo Figueiredo, Maria C. Silva, Mariana V. Tavares, Maria P. M. Marques & Luís A. E. Batista de Carvalho. (2021) A New Look into Cancer—A Review on the Contribution of Vibrational Spectroscopy on Early Diagnosis and Surgery Guidance. Cancers 13:21, pages 5336.
Crossref
Crossref
Veronika Holubekova, Zuzana Kolkova, Marian Grendar, Dusan Brany, Dana Dvorska, Igor Stastny, Marianna Jagelkova, Katarina Zelinova, Marek Samec, Alena Liskova, Zuzana Laucekova, Erik Kudela, Martina Bobrovska, Michal Kalman, Pavol Zubor & Zuzana Dankova. (2020) Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study. International Journal of Molecular Sciences 21:19, pages 7288.
Crossref
Crossref
Ishita Gupta, Balsam Rizeq, Semir Vranic, Ala-Eddin Al Moustafa & Halema Al Farsi. (2020) Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets. International Journal of Molecular Sciences 21:18, pages 6750.
Crossref
Crossref
Sergio Liarte, José Luis Alonso-Romero & Francisco José Nicolás. (2018) SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression. Frontiers in Endocrinology 9.
Crossref
Crossref
Jianing Yan, Shibo Ying & Xiujun Cai. (2018) MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Sarmistha Mitra. (2017) MicroRNA Therapeutics in Triple Negative Breast Cancer. Archives of Pathology and Clinical Research 1:1, pages 009-017.
Crossref
Crossref
Yi Sang, Jianjun Tang, Siwei Li, Liping Li, XiaoFeng Tang, Chun Cheng, Yanqin Luo, Xia Qian, Liang-Ming Deng, Lijuan Liu & Xiao-Bin Lv. (2016) LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression. Scientific Reports 6:1.
Crossref
Crossref